Description: Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. researches, develops, produces, distributes, and sells infectious disease diagnostic reagents and vaccines in China and internationally. The company provides COVID 19, HIV and HTLV, Hepatitis, EV-71, and Tuberculosis diagnostics test kits; Hepatitis C and Syphilis detection reagents; automated immunoassays; ELISA kits and rapid tests for infectious disease diagnostics; chemiluminescence and clinical chemistry reagents; immunodiagnostic reagents; and Hepatitis E and human papillomavirus vaccines. It serves blood banks, hospitals and clinics, reference laboratories, border inspection centers, blood-processing companies, and research institutes. The company was founded in 1991 and is headquartered in Beijing, China.
Home Page: www.ystwt.com
No. 31 Kexueyuan Road
Beijing,
102206
China
Phone:
86 10 5952 8888
Officers
| Name | Title |
|---|---|
| Mr. Zixin Qiu | Chairman, GM & Board Sec. |
| Mr. Yiyong Zhao | Chief Financial Officer |
| Mr. Yimin Li | Chief Engineer |
| Mr. Xiangzhong Ye | Deputy GM & Director |
| Ms. Lingzhi Zhao | Deputy GM & Director |
| Li Gang | Accounting Supervisor |
Exchange: SHG
Country: CN : China
Currency: Renminbi (¥)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 25.4935 |
| Price-to-Book MRQ: | 10.7591 |
| Price-to-Sales TTM: | 11.2504 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3103 |